ESPGHAN Webinars

In the past year, we have experienced an increased demand for virtual education due to our limitations with face-to-face meetings.
In 2021, ESPGHAN has thus launched a webinar format for everyone who wants to continue their education in PGHN despite the COVID pandemic and related restrictions. Due to the success of our 2021 series we will continue the webinars in 2024. Please monitor this webpage for respective updates.

Registration

Who can apply?
The webinar is open for members and non-members and all age groups. Participants need to register with the ESPGHAN Office.  The participation is free of charge. To register, please send an email to office@espghan.org
Registrations are on a first-com, first-served basis so we recommend to register early.  We reserve the right to close registration if capacity is reached before the below mentioned deadlines.

Upcoming 2024

May - NAFLD to MASLD; what’s in a name? The importance of a nomenclature change and what this means for paediatricians.

Date: 2nd of May, 2024

Time: 17:00-18:00 CEST.

Registration deadline: 1st of May, 2024.

About the webinar: A recent Delphi process resulted in a change in nomenclature for NAFLD to the term MASLD (metabolic-dysfunction associated steatotic liver disease). This has significance for children with the condition and for their clinicians. Dr Bart Koot represented ESPGHAN in the consensus development and will speak about the process and the advantages of the name change for paediatrics. Dr Jake Mann will delve into the nuances that separate out the paediatric condition from the adult one and the relevance of our approach to children with steatotic liver disease. He will present a multi-society statement endorsing the nomenclature change highlighting issues relevant to paediatrics.

Speakers: Dr. Jake Mann and Dr. Bart Koot

June - Dietary treatment of eosinophilic esophagitis

Date: 5th of June, 2024
Time: 17:00-18:00 CEST.
Registration deadline: 4th of June, 2024.

 

Speaker: Lucy Jackman


About the webinar:

Dietary treatment is one of the main treatment options for eosinophilic esophagitis (EoE), offering a steroid free treatment option. However, implementing it in practice can be confusing, challenging and variable between centres. Recent published guidelines have standardised the dietary treatment of EoE. We will explore these, practical tips for managing children with EoE and key considerations.

About the presenter:

Lucy Jackman is a clinical dietitian based at Great Ormond Street Hospital in London, UK.  She is a member of the British Society of paediatric gastroenterology, hepatology and nutrition BSPGHAN working group for EoE and is co-author on a number of published papers by the working group.

2023 Archive

July - Vegetarian and vegan diets and the health and development of children

Date July 17, 2023. 17:00-18:00 CEST

Registration deadline: July 16, 2023.

Speakers - Malgorzata Desmond

PhD and clinical dietitian specializes in nutritional therapy of the digestive system, autoimmune and cardiometabolic diseases, as well as in nutritional counselling for vegans and vegetarians. She is currently aa honorary research fellow at the UCL Great Ormond Street Institute of Child health and runs a private dietetic practise in Warsaw.

Description

Plant-based diets are increasingly recommended for individual as well as planetary health; however, evidence on the health and dietary intakes of children on vegetarian, and particularly on vegan diets is limited. During the webinar Dr Desmond will present the existing evidence on this topic and elaborate on the implications of scientific findings and present recommendations on how to customize the dietary and supplemental advice to vegans compared with vegetarians.

September - Portal hypertension in children; Variceal classification and endoscopic management

Date: September 19, 2023. 16:00 – 17:30 CEST

Registration deadline:  September 18, 2023

Speakers:

Dr.Tassos Grammatikopoulos (Chair)
Dr. Hubert Van der Doef

Description:

The Portal Hypertension(PHT) Special Interest Group(SIG) are hosting their first webinar on the topic. We would like to invite members to join us in a session with lectures and interactive discussion on PHT, variceal classification and endoscopic mamagement. Members of different experience and background are welcomed to this online event. This webinar is part of a series of similar combined educational and clinical management events around PHT, that will be offered.

September -The nutritional management of paediatric liver disease

Date: September 15, 2023. 18:00 - 19:00 CEST
Registration Deadline: September 14

Speaker

Sara Mancell is a paediatric dietitian with over 20 years of clinical experience. Her main research interest and the focus of her current PhD study is medium-chain triglyceride supplementation in cholestatic liver disease.  

Content

Children with liver disease are at high risk of malnutrition. In addition to difficulties with absorbing, metabolising and storing nutrients, the consequences of liver failure may increase the demand for nutrients and have a detrimental effect on nutrient intake. This webinar will focus on nutritional assessment and management and will include practical guidance on managing the most common nutritional complications in children with liver disease.  

October - Coeliac Disease: Talking to your pathologist

Date: October 26, 2023. 17:00 – 18:00 CET

Registration deadline:  October 25, 2023

Speakers: 
Alina Popp

Pediatric Gastroenterologist
National Institute for Mother and Child Health, Bucharest, Romania

Tiberiu Georgescu
Pathologist
National Institute for Mother and Child Health, Bucharest, Romania

Description:
The traditional histological evaluation of CD has undergone marked changes in recent years, and in the ESPGHAN guidelines 2012 and 2020 at least four biopsies from the distal duodenum and at least one from the duodenal bulb should be taken while the patient is on a gluten-containing diet. Additionally, the use of validated standard operating procedures (SOPs) with correct orientation and cutting of the duodenal specimen is considered critical for an accurate evaluation of the mucosal architectural changes. But , in a recent study in paediatric patients, only approximately half of the biopsies were considered optimally oriented. Moreover sometimes it may be challenging to establish if a biopsy is correctly oriented. Thus,  in  cases of doubt or of discordant results between TGA-IgA-results and histopathology, re-cutting of biopsies and/or second opinion from an experienced pathologist may be needed.

In this webinar we will discuss in detail the problematic of histology assessment from the clinician but also from the pathologist point of view.

October - Liver transplantation: when is a child too sick to transplant?
November - Update on the management of Wilson’s disease in children

Date: November 28, 2023. 17:00 – 18:00 CET

Registration deadline:  November 27, 2023

Speakers: 
Piotr Socha
Tudor Lucian Pop

Description:

Wilson’s disease (WD) is a rare genetic disorder of the copper metabolism, resulting in a range of disfunctions in multiple organs. In children, the main form is liver disease, highly variable, from increased transaminases levels to cirrhosis or acute liver failure. WD may have fatal evolution, but an early diagnosis and proper treatment could improve the evolution of disease in children. A high level of suspicion should be present for diagnosis based on a combination of clinical signs, biochemical tests, histology, and genetics. This webinar will discuss the recent advances in screening, diagnosis and treatment of WD in pediatric population.

This webinar is organized by the ESPGHAN Hepatology Committee

November - Coeliac Disease: Talking to your immunologist

Date: November 30, 2023. 17:00 – 18:00 CET
Registration deadline:  November 29, 2023

Speakers: 
Renata Auricchio, MD, PhD
Pediatric Gastroenterologist
Associate Professor in Pediatrics
Department of Translation Medical Science, Pediatric Section
European Laboratory for the Investigation of Food Induced Disease (ELFID)
University Federico II, Naples

Ilma Korponay-Szabo M.D., Ph.D.
Department of Pediatrics, Faculty of Medicine, University of Debrecen & Celiac Disease Center, Heim Pál National Paediatric Institute, 1089 Budapest, Hungary

Description:
ESPGHAN Guidelines for Diagnosing Coeliac Disease of 2012 and 2020 establish the possibility of the non-biopsy approach for CD diagnosis in children with symptoms suggestive of CD but also eventually in asymptomatic children, with serum levels of_10 times the upper limit of normal of TGA-IgA  and   positive EMA-IgA in a second serum sample. Thus reliable testing is crucial to avoid under and over diagnosis and in this respect guidelines recommend to use only  antibody tests with proper calibrator curve-based calculation, and having the 10 x ULN value within their measurement range. Reports on TTG should specify the test used and the cut off levels. 
EMA results should contain the specification of the investigated immunoglobulin class, the cutoff dilution, interpretation (positive or negative), the highest dilution still positive and the specification of the substrate tissue. Also, laboratories providing CD-specific antibody test results for diagnostic use should continuously participate in quality control programmes at a national or an international level. Efficiency of the test together with challenging aspects of test interpretation will be addressed during this webinar by relevant experts in the field.

January -The current state of evidence for the Crohn's Disease Exclusion Diets and additional novel dietary therapies in IBD.

Date: January 16, 2024. 17:00-18:00 CET

Registration deadline:  15th of January 2024 

Speakers: Rotem Sigall Boneh

Description: EEN is the gold standard therapy in Crohn’s Disease however, there are new dietary therapies emerging. This webinar covers these new therapies, especially the CDED that is growing in use all over Europe, helping both GI’s and clinical dietitians to gain knowledge in these intriguing therapies.

About the webinar:

EEN is considered the gold standard dietary therapy for CD; however, implementing it over the long term can be challenging. The CDED demonstrated better tolerance with comparable efficacy in achieving clinical remission. Cumulative data have been published to support the use of CDED in various conditions, different populations, and diverse outcomes. In this presentation, we will explore the growing body of evidence surrounding the CDED and other innovative dietary interventions.

About the presenter:

Rotem Sigall Boneh is a clinical and research dietitian based at Wolfson Medical Centre in Holon, Israel. She is the founder of D-ECCO, the dietitian committee within the European Crohn and Colitis organization. Additionally, she is a co-founder of the Crohn's Disease Exclusion Diet (CDED) and has played a pivotal role in leading clinical trials in this field. Currently, she is working on her Ph.D. at Amsterdam University, focusing on the role of CDED in the management of Crohn's Disease.

April - Complementary feeding – When, What and How?

Date: 11th of April, 2024

Time: 17:00-18:00 CEST.

Registration deadline: 10th of April, 2024.

About the webinar:

The introduction of foods other than milk to the infant diet is a topic of much debate among healthcare professionals, policymakers and parents. Timing is an important consideration and when to introduce complementary foods has been widely discussed. What should be given is also a topic of interest. Are all foods equal? Do some deserve special consideration? For example, foods containing allergens. More recently the question of how to feed infants during this transitional period has been raised. The traditional way, where infants are offered foods by spoon, and feeding progresses through stages from purees to mashed then lumpy foods has been rejected by some parents and caregivers. Baby-led weaning is now favoured by some. But does this meet the needs of growing infants? All this and much more including new guidance on complementary feeding from the World Health Organisation will be presented and discussed at our upcoming webinar where you will have the chance to be updated by our expert speaker and discuss with colleagues from across Europe and beyond.

Information on the speaker:

Dr Julie Lanigan RD PhD FBDA. Paediatric Dietitian and associate Professor (Hon) at UCL GOS Institute of Child Health and Lecturer in Dietetics, Programme lead for the APP Masters in Paediatric Dietetics, University of Plymouth Julie Lanigan, is a paediatric dietitian specialising in paediatric weight management and an academic researcher with more than 25 years experience investigating the effects of early nutrition on long-term health in children. Julie is a founding director of TrimTots Community Interest Company set up with UCL Business to develop evidence-based interventions for the prevention and treatment of childhood obesity. Current projects include multi-centre infant feeding trials and studies involving cultural adaptations and evaluations of the Planet Munch Healthy Lifestyle Programme – an intervention for prevention of obesity in preschool children. Julie has published widely. She is a regular invited speaker at national and international conferences and lectures in childhood nutrition at UCL and the University of Plymouth.

March - Next Generation Enteral Nutrition Therapy if Paediatric Crohn’s Disease

Date  March 04, 2024. 17:00- 18:00 CET

Registration deadline: March, 03. 2024

Speaker: Konstantinos Gerasimidis

Desciption: The presenter will discuss the use of enteral nutrition in the various aspects of Crohn’s disease management including exclusive enteral nutrition with and without elimination diet in management of active luminal disease, as maintenance therapy post-EEN induction, for peri-surgical optimisation and as combination therapy with other advance therapies.

About the webinar:

We will discuss the use of enteral nutrition in the various aspects of Crohn’s disease management including exclusive enteral nutrition with and without elimination diet in management of active luminal disease, as maintenance therapy post-EEN induction, for peri-surgical optimisation and as combination therapy with other advance therapies.

About the presenter:

Professor Konstantinos is a Professor of Clinical Nutrition at the School of Medicine, University of Glasgow and is a Dietitian by training. He explores the interaction between diet and the gut microbiome in all age IBD and has a particular interest in dietary management of CD and UC. He has been faculty in various committees and working groups including ESPGHAN, ECCO and ESPEN and currently leads a research team of 23 members.